.

 
 
 
 
 
Send to a Friend   print  
19:3214.11.2024
AMSTERDAM, 14. november, AFP-BNS – Euroopa Ravimiamet (EMA) kiitis neljapäeval osaliselt heaks taotluse lubada turule kauaoodatud uus Alzheimeri tõve ravim, millele müügiloa andmise amet varem tagasi lükkas.
Please log in to read full article
Save as: 

Sorry, you haven't subscribed for this topic.

 

How to register as user of BNS?

Valid Service Agreement is the basis for getting access to BNS Terminal. Please send your contact data and we will contact you as soon as possible.

 
 
 
 

There are no news lines.

 
AS Postimees Grupp Switchboard: +372 610 8800 BNS Ethics Code
Tartu mnt 80 Common e-mail: bns@bns.ee
10112 Tallinn, Estonia

© Baltic News Service.
All rights reserved.